Results 81 to 90 of about 16,680,452 (299)
High-Density Lipoprotein Cholesterol and the Role of Statins.
Low levels of high-density lipoprotein cholesterol (HDL-C) are currently considered to be a major risk factor for the development of coronary artery disease (CAD). Deficiencies in the HDL metabolic pathway promote atherosclerosis and contribute to CAD. Low HDL-C levels are included in the Framingham 10-year risk assessment for CAD although they are not
Chong, Pang H +2 more
openaire +3 more sources
The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol, or NHHR, has garnered increased attention because of its connection to metabolic diseases.
Ma Yanming +8 more
doaj +1 more source
BackgroundThis study aimed to explore the link between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and sarcopenia in elderly adults using data from the National Health and Nutrition Examination Survey ...
Yi Lin +3 more
doaj +1 more source
Correlation Monocyte Count, High Density Lipoprotein Cholesterol Levels and Monocyte High Density Lipoprotein Cholesterol Ratio with hsCRP Levels in Hypertension Patient [PDF]
Background: Hypertension is a condition which blood pressure in blood vessels increases chronically. Previous studies have shown that hypertension is associated with an inflammatory process involving innate and adaptive immune responses. Hypertension led
Rochman CHOLIQ +2 more
doaj +1 more source
This study reveals a novel GC therapy targeting cholesterol homeostasis. Inhibiting the SCAP sterol‐sensing domain causes lethal ER stress via cholesterol accumulation, paradoxically forcing continuous synthesis that triggers ferroptosis. The findings link sterol sensing, metabolic dysregulation, and ferroptosis, establishing an anti‐cancer paradigm ...
Qianqian Xu +17 more
wiley +1 more source
Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey
We present results of the second survey of the Italian Multicenter Study on Low-Density Lipoprotein Apheresis (IMSLDLa-WG/2). The study involved 18 centers in 2009, treating 66 males and 35 females, mean age 47 +/- 18 years.
MOROZZI, CLAUDIA +3 more
core +1 more source
A Bivariate Genome-Wide Approach to Metabolic Syndrome STAMPEED Consortium [PDF]
OBJECTIVE The metabolic syndrome (MetS) is defined as concomitant disorders of lipid and glucose metabolism, central obesity, and high blood pressure, with an increased risk of type 2 diabetes and cardiovascular disease.
O'Reilly, Paul F. +177 more
core +1 more source
As a pilot phase of the Central Asian Genomic Diversity Project, whole‐genome sequencing of 166 individuals from 20 Central Asian and Afghan Hazara populations reveals fine‐scale substructure shaped by repeated trans‐Eurasian migration and admixture. Integrated analyses uncover post‐admixture adaptation, archaic introgression, and medically relevant ...
Mengge Wang +11 more
wiley +1 more source
Large‐scale UK Biobank analyses identify clinical and proteomic signatures for early prediction of valvular heart disease and its subtypes. Proteins add predictive value for VHD, AVS, and MVR, with outcome‐specific compact panels showing translational potential. Multi‐layer evidence highlights matrix remodeling, protease regulation, immune inflammation,
Zhihao Jiang +10 more
wiley +1 more source
Influences of the neutrophil-HDL ratio, monocyte-HDL ratio and lymphocyte-HDL ratio on patients with acute exacerbation of chronic heart failure [PDF]
Background: To investigate the role of the neutrophil/ high-density lipoprotein cholesterol ratio, monocyte/ high-density lipoprotein cholesterol ratio, and lymphocyte/high-density lipoprotein cholesterol ratio in the diagnosis and management of patients
Zeng Chuixu, Wei Xu, Liu Guiying
doaj +1 more source

